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Abstract
BACKGROUND: Acute nonspecific mesenteric lymphadenitis refers to a common pediatric problem that has no 
specific treatment.
CASE REPORT: In our study, we describe seven children presenting with abdominal pain as the main symptom of a 
disease. All patients were treated with prednisone 1 mg/kg (max 40 mg daily) for a maximum of 5 days. In addition, 
we evaluated the intensity of the pain using a numeric rating scale and achieved a clinically important difference in 
acute pain relief of 85.3%. After administering corticosteroid therapy, the abdominal pain resolved after 1.7 (1–4) 
days in all children without any other disturbances.
CONCLUSION: In selective patients with mesenteric lymphadenitis, prednisone can be used as an acceptable form 
of treatment to reduce the duration of abdominal pain.
Edited by: Igor Spiroski
Citation: Pavlovic M, Rokvic Z, Berenji 
K. Prednisone for the Treatment of Acute 
Nonspecific Mesenteric Lymphadenitis. Open 
Access Maced J Med Sci. 2020 Jul 25; 8(C):82-85. 
https://doi.org/10.3889/oamjms.2020.4219
Keywords: Mesenteric lymphadenitis; Corticosteroids; 
Abdominal pain; Children
*Correspondence: Momcilo Pavlovic, Children’s 
Ambulatory Care Center Subotica, Prvomajska 
20, 24000 Subotica, Serbia. Tel.: +381638233331. 
E-mail: momodec@tippnet.rs
Received: 20-Dec-2019
Revised: 16-Jul-2020
Accepted: 21-Jul-2020
Copyright: © 2020 Momcilo Pavlovic, Zeljko Rokvic, 
Karolina Berenji
Funding: This research did not receive any financial 
support
Competing Interests: The authors have declared that no 
competing interests exist
Open Access: This is an open-access article distributed 
under the terms of the Creative Commons Attribution-
NonCommercial 4.0 International License (CC BY-NC 4.0)
Introduction
Primary or acute nonspecific mesenteric 
lymphadenitis (ANML) is a recognized and well-known 
cause of acute abdominal pain in children. However, 
diagnosis of this self-limiting condition is not always 
straightforward due to the age of the child, lack of 
specific signs, and common diagnostic criteria [1], [2]. An 
underlying viral infection (adenovirus, herpes simplex, 
influenza virus) is thought to be the cause in most cases 
of ANML. Meanwhile other reported causes of mesenteric 
lymphadenitis (or secondary) include bacterial (yersiniosis, 
salmonellosis, and tubercle bacilli), tumor mesenteric 
lymphadenitis (lymphoma and acute leukemia), parasitic, 
autoimmune diseases, as well as immunodeficiencies 
[3]. In clinical practice, these conditions are medical 
rarities, and the most common dilemma is distinguishing 
appendiceal inflammation from that of ANML [4]. All 
children with ANML presented with abdominal pain, 
whereas other characteristic symptoms include fever, 
nausea, vomiting, diarrhea, constipation, and anorexia, 
accompanied with normal or mild elevated markers of 
inflammatory conditions [4], [5].
In addition to the fact that ANML has no 
effective therapy, the supportive treatment and 
time-intensive “wait and see” approach often becomes 
discouraging for both patients and their families. 
Against this backdrop, the goal of the current study 
was to evaluate the efficacy of oral prednisone for pain 
relief in children with ANML.
Case Report
Seven patients (three boys and four girls) who 
presented in the Children’s Ambulatory Care Center 
Subotica between September 2018 and May 2019 
with ANML were prospectively analyzed. The average 
patient age was 8.2 years (range: 5.3–13.7 years). 
All patients provided a clinical history after which a 
complete physical examination was performed by 
pediatrician gastroenterologist and pediatric surgeon. 
The diagnosis of ANML in children was made in 
accordance (a) characteristic signs and symptoms; 
(b) an abdominal ultrasound demonstrating enlarged 
three or more lymph nodes, short-axis diameter of 8 
mm or more in at least one of them (Figure 1); and (c) 
laboratory and ultrasound exclusion of appendicitis 
along with other causes of abdominal pain [4], [5].
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The ethical board at our center gave its approval 
to the study and all parents gave written consent. The 
patients subjectively evaluated the intensity of the pain 
using numeric rating scale (NRS) with numbers ranging 
from 0 to 10 with 0 denoting “no pain” and 10 representing 
“worst possible pain” as the endpoints [6]. It is notable that 
we only included patients with pain scores above 6/10 
in the study. Pain scores below 4/10 were considered 
as a satisfactory therapeutic response. Six patients 
had vomiting (85.7%), five anorexia (71.4%), four fever 
(57.4%), and one diarrhea (14.2%) and constipation 
(14.2%). Laboratory tests (complete blood cell count, 
C-reactive protein-CRP, amylase, liver function tests, 
urea, creatinine, urinalysis, stool parasite analysis, and 
stool culture) were found to be normal. During episodes 
of pain, we recommended acetaminophen for analgesia. 
Following the exclusion of other diseases, patients were 
treated with oral prednisone 1 mg/kg (maximum 40 mg) 
once daily for between 2 and 5 days. The last dose of 
prednisone was received by patients 1 day after NRS 
score was found to be below 4/10.
The characteristics of abdominal pain in our 
children are depicted in Table 1.
All other pre-existing signs and symptoms 
were found to disappear during the corticosteroid 
therapy. Even adverse effects of corticosteroids did 
not show up. Two patients were examined on control 
ultrasound 1 month after inclusion in the study, whereas 
mesenterial lymph nodes were normal.
Discussion
As stated before, ANML is a self-limiting 
disease with mostly no specific cure. The treatment 
overlaps with many pain syndromes and includes 
bed rest, hydration (infusion therapy based on the 
indications), and acetaminophen or a non-steroidal anti-
inflammatory agent [7]. To the best of our knowledge, 
this marks the first attempt to treat ANML with 
corticosteroids. We searched for the articles published 
in PubMed, Embase, and Cochrane Library until the 
month of May 2019 with no language restrictions using 
the following keywords: “Acute nonspecific mesenteric 
lymphadenitis,” “mesenteric lymphadenitis,” and 
“treatment” or “corticosteroids.”
Corticosteroid therapy has been found to 
be beneficial in some viral infections alone, or as 
adjuvants with active antimicrobial agents in many 
infectious diseases [8]. Short-term corticosteroid 
therapy reduces acute inflammation by inhibiting the 
activation of inflammatory cells. In addition, it lowers 
the pain in acute sinusitis as well as upper respiratory 
tract infections [9]. Studies in adults and children 
reveal that a single dose of oral dexamethasone in 
combination with antibiotics increased the likelihood of 
resolution and improvement of pain in patients with a 
severe streptococcal sore throat [10]. Correspondingly, 
Roy et al. found that oral dexamethasone, 0.3 mg/kg 
for 7 days is effective for pain relief in acute exudative 
pharyngitis among children with suspected infectious 
mononucleosis [11]. However, reports pertaining to the 
effectiveness of corticosteroids for control of swollen 
lymph glands in mononucleosis are conflicting [12]. 
Meanwhile corticosteroids do reduce post-operative 
pain in children and facilitate the prevention of post-
operative nausea and vomiting [13].
The controversy is attributed to the potential 
benefits and adverse events of short-course 
therapy of corticosteroids in self-limiting diseases 
such as ANML. At times, health-care providers are 
reluctant to prescribe corticosteroids due to their 
immunosuppressive tendencies and potential side 
effects. However, reports of these side effects during 
short-course corticosteroid therapy are anecdotal and 
largely self-limiting (peritonsillar abscess, encephalitis, 
and myocarditis) [12], [14]. To that end, it is noteworthy 
that we did not observe any side effects induced by 
corticosteroid in our patients.
Figure 1: Mesenteric lymph node enlargement on abdominal 
ultrasound in a 7-year-old girl with acute nonspecific mesenteric 
lymphadenitis
Table 1: Characteristics of abdominal pain in seven patients affected with acute nonspecific mesenteric lymphadenitis
Case number Localization of abdominal 
pain
Nocturnal 
abdominal pain
Duration of pain before 
treatment (days)
Duration of pain after 
start of treatment (days)
Pain intensity before 
treatment (1–10)
Pain intensity after 
treatment (1–10)
Reduction from baseline 
pain difference (%)
1 Ileocecal Yes 6 1 9 0 9 (100)
2 Periumbilical No 7 2 8 1 7 (87.5)
3 Periumbilical No 6 1 8 0 8 (100)
4 Periumbilical No 14 4 7 2 5 (71.4)
5 Periumbilical Yes 3 1 8 0 8 (100)
6 Ileocecal and periumbilical No 3 2 8 2 6 (75)
7 Ileocecal Yes 6 1 10 0 10 (100)
Mean 6.4 1.7 8.2 0.7 7.5 (85.3)
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In ANML, children commonly recover within 
2–3 weeks, although symptoms persist for 3–10 
weeks in half of the patients [7], [15]. Meantime of 
abdominal pain before therapy in our patients was 
less than a week; however, the recovery time after 
treating with prednisone was 1.7 days. We were 
guided by recommendations of European Society 
for Paediatric Anaesthesiology that the target should 
be to achieve and maintain pain scores below the 
intervention threshold of 4 (on a 10-point scale) [16]. 
Clinically important differences in acute pain relief 
using patients’ perception have an impact on which 
analgesic interventions are regarded useful. The 
minimum clinically important pain reductions before 
and after the interventions have varied greatly between 
studies, with relative difference ranging from 13% to 
85% [17]. In our study, the relative difference is 85.3%, 
which is a large decrease to perceive relief. In addition, 
we can assume that the resolution of pain and other 
disturbances can prevent dehydration and obviate the 
need for infusion therapy.
Notably, we did not use prednisone for all 
children with ANML in our center, nor do we support 
their routine use in ANML. We believe that corticosteroid 
therapy is only needed in severe forms of abdominal 
pain.
Since research on this subject is extremely 
limited, more placebo-controlled studies with greater 
number of patients are necessitated to confirm these 
findings.
Conclusion
Pain control should be a therapeutic goal 
in patients with ANML. In this regard, prednisone, as 
adjuvant therapy in conjunction with analgesics, is an 
adequate and safe therapy, especially in severe forms 
of this disease.
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